Evidence map›Paper›PMID 26797908›Full record

ArticleClinical orthopaedics and related research2016

Biofilm Antimicrobial Susceptibility Increases With Antimicrobial Exposure Time.

Paulo Castaneda, Alex McLaren, Gamuchirai Tavaziva, Derek Overstreet

Open access · greenAbstract readComparative Study
In one paragraph

Article in Clinical orthopaedics and related research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 134 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. UropathogenicInternational journal of molecular sciences · 2025
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Paulo CastanedaBanner - University Medical Center Phoenix, 1320 N 10th Street, Phoenix, AZ, 85006, USA. pcastan6@gmail.com.ORCID http://orcid.org/0000-0003-0653-4380
Alex McLarenBanner - University Medical Center Phoenix, 1320 N 10th Street, Phoenix, AZ, 85006, USA.
Gamuchirai TavazivaCenter for Interventional Biomaterials, Arizona State University, Tempe, AZ, USA.
Derek OverstreetSonoran Biosciences, Chandler, AZ, USA.
Arizona State University · USUniversity of Arizona · US

Funding

Surface-covering gels for broad-spectrum antimicrobial protection following openR41AR065917 · NIAMS · SONORAN BIOSCIENCES, INC. · PI VERNON, BRENT L · 2014 to 2014
$150k
NIAMS NIH HHS R41 AR065917
6 · The paper itself

Abstract

backgroundThe antimicrobial concentration required to kill all the bacteria in a biofilm, known as the minimum biofilm eradication concentration (MBEC), is typically determined in vitro by exposing the biofilm to serial concentrations of antimicrobials for 24 hours or less. Local delivery is expected to cause high local levels for longer than 24 hours. It is unknown if longer antimicrobial exposures require the same concentration to eradicate bacteria in biofilm. Questions/purposes Does MBEC change with increased antimicrobial exposure time?

methodsBiofilms were grown for 24 hours using five pathogens (methicillin-sensitive Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, and Pseudomonas aeruginosa) and then exposed to four antimicrobials regimens: tobramycin, vancomycin, and tobramycin combined with vancomycin in 3:1 and 1:1 ratios by weight in concentrations of 62.5, 125, 250, 500, 1000, 2000, 4000, and 8000 μg/mL for three durations, 1, 3, and 5 days, in triplicate. MBEC was measured as the lowest concentration that killed all bacteria in the biofilm determined by 21-day subculture.

resultsMBEC was lower when antimicrobial exposure time was longer. For the staphylococcus species, the MBEC was lower when exposure time was 5 days than 1 day in 11 of 12 antimicrobial/microorganism pairs. The MBEC range for these 11 pairs on Day 1 was 4000 to > 8000 μg/mL and on Day 5 was < 250 to 8000 μg/mL. MBEC for tobramycin/P. aeruginosa was 2000 μg/mL on Day 1 and ≤ 250 μg/mL on Day 5, and for E. coli, 125 μg/mL on Day 1 and ≤ 62.5 on Day 5.

conclusionsAlthough antimicrobial susceptibility was lower for longer exposure times in the microorganisms we studied, confirmation is required for other pathogens. Clinical Relevance One-day MBEC assays may overestimate the local antimicrobial levels needed to kill organisms in biofilm if local levels are sustained at MBEC or above for longer than 24 hours. Future studies are needed to confirm that antimicrobial levels achieved clinically from local delivery are above the MBEC at relevant time points and to confirm that MBEC for in vitro microorganisms accurately represents MBEC of in vivo organisms in an clinical infection.

Indexed as

Anti-Bacterial AgentsBiofilmsDose-Response Relationship, DrugEscherichia coliMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsMicrobial ViabilityPseudomonas aeruginosaStaphylococcusStaphylococcus epidermidisTime FactorsTobramycinVancomycinAnti-Bacterial AgentsTobramycinVancomycin

Identifiers

PMID26797908
PMCPMC4887352
OpenAlexW2341594946

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.